These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 14295461)

  • 1. A COMPARISON OF REAGENTS IN THE ABREACTION OF MUTE SCHIZOPHRENICS.
    Abenson MH; Beattie RT
    Acta Psychiatr Scand; 1964; 40(3):234-9. PubMed ID: 14295461
    [No Abstract]   [Full Text] [Related]  

  • 2. A preliminary investigation into abreaction comparing methedrine and sodium amytal with other methods.
    HOUSTON F
    J Ment Sci; 1952 Oct; 98(413):707-10. PubMed ID: 13000335
    [No Abstract]   [Full Text] [Related]  

  • 3. Controlled interviews using drugs.
    Smith BM; Hain JD; Stevenson I
    Arch Gen Psychiatry; 1970 Jan; 22(1):2-10. PubMed ID: 4391098
    [No Abstract]   [Full Text] [Related]  

  • 4. A comparison of the effects of oxypertine and trifluoperazine in withdrawn schizophrenics.
    Hunt PV
    Br J Psychiatry; 1967 Dec; 113(505):1419-24. PubMed ID: 4865294
    [No Abstract]   [Full Text] [Related]  

  • 5. A CONTROLLED EVALUATION OF BUTAPERAZINE IN CHRONIC SCHIZOPHRENIC PATIENTS.
    BISHOP MP; GALLANT DM; NESSELHOF W; SPREHE DJ
    Dis Nerv Syst; 1964 Nov; 25():674-83. PubMed ID: 14236800
    [No Abstract]   [Full Text] [Related]  

  • 6. COMPARISON OF DRUG EFFECTS ON APPROACH, AVOIDANCE, AND ESCAPE MOTIVATION.
    BARRY H; MILLER NE
    J Comp Physiol Psychol; 1965 Feb; 59():18-24. PubMed ID: 14282402
    [No Abstract]   [Full Text] [Related]  

  • 7. PSYCHOLOGICAL AND CLINICAL INVESTIGATION OF THE TREATMENT OF ANXIOUS OUT-PATIENT WITH THREE BARBITURATES AND PLACEBO.
    REYNOLDS E; JOYCE CR; SWIFT JL; TOOLEY PH; WEATHERALL M
    Br J Psychiatry; 1965 Jan; 111():84-95. PubMed ID: 14261732
    [No Abstract]   [Full Text] [Related]  

  • 8. DIFFERENTIAL EFFECTS OF PSYCHOTROPIC DRUGS. AN EXPLORATION USING COMPARISONS OF SEVERAL AGENTS.
    JANECEK J; SCHIELE BC; TROUSDALE W; LARSON T
    Dis Nerv Syst; 1965 May; 26():292-301. PubMed ID: 14288239
    [No Abstract]   [Full Text] [Related]  

  • 9. Response to trifluoperazine-amobarbital in outpatients with anxiety. (A double-blind, placebo-controlled study).
    Guthrie MB; Free SM
    Dis Nerv Syst; 1969 Mar; 30(3):195-200. PubMed ID: 4886703
    [No Abstract]   [Full Text] [Related]  

  • 10. PERSONALITY FACTORS IN VARIABILITY OF RESPONSE TO PHENOTHIAZINES.
    HENINGER G; DIMASCIO A; KLERMAN GL
    Am J Psychiatry; 1965 May; 121():1091-4. PubMed ID: 14283305
    [No Abstract]   [Full Text] [Related]  

  • 11. THE EFFECTS OF PHENOTHIAZINE ON DISORDERED THOUGHT IN SCHIZOPHRENIA.
    CHAPMAN LJ; KNOWLES RR
    J Consult Psychol; 1964 Apr; 28():165-9. PubMed ID: 14142951
    [No Abstract]   [Full Text] [Related]  

  • 12. Abreaction before ECT?
    Sivakumar K; Mills CS; Gupta K
    Br J Psychiatry; 1991 Sep; 159():444-5. PubMed ID: 1958966
    [No Abstract]   [Full Text] [Related]  

  • 13. [It is absurd to treat schizophrenia with abreaction].
    von Sivers E
    Lakartidningen; 1990 Nov; 87(48):4055. PubMed ID: 2263116
    [No Abstract]   [Full Text] [Related]  

  • 14. Global ratings compared to rating scales in evaluating trifluoperazine-amobarbital in anxious psychoneurotic outpatients.
    Bercel NA
    Behav Neuropsychiatry; 1971; 2(11):15-9. PubMed ID: 4935767
    [No Abstract]   [Full Text] [Related]  

  • 15. SYKES TF: EXTRAPYRAMIDAL SIDE EFFECTS AND THERAPEUTIC RESPONSE.
    BISHOP MP; GALLANT DM
    Arch Gen Psychiatry; 1965 Aug; 13():155-62. PubMed ID: 14314761
    [No Abstract]   [Full Text] [Related]  

  • 16. Abreaction before ECT.
    Howells R; Patrick M
    Br J Psychiatry; 1992 Jan; 160():132. PubMed ID: 1544003
    [No Abstract]   [Full Text] [Related]  

  • 17. Dissociative disorder, conversion disorder and the use of abreaction in a 22 year old male.
    Chancellor AM
    N Z Med J; 1982 Jun; 95(710):418-9. PubMed ID: 6955663
    [No Abstract]   [Full Text] [Related]  

  • 18. Combined drug therapy of chronic schizophrenics. Controlled evaluation of placebo, dextro-amphetamine, imipiramine, isocarboxazid and trifluoperazine added to maintenance doses of chlorpromazine.
    CASEY JF; HOLLISTER LE; KLETT CJ; LASKY JJ; CAFFEY EM
    Am J Psychiatry; 1961 May; 117():997-1003. PubMed ID: 13691268
    [No Abstract]   [Full Text] [Related]  

  • 19. THE PROBLEM OF SELECTING DRUG-FREE SCHIZOPHRENICS FOR RESEARCH.
    CHAPMAN LJ
    J Consult Psychol; 1963 Dec; 27():540-2. PubMed ID: 14086800
    [No Abstract]   [Full Text] [Related]  

  • 20. A COMPARISON OF SKF-7261 AND TRIFLUOPERAZINE (STELAZINE) IN THE TREATMENT OF CHRONIC SCHIZOPHRENIC PATIENTS.
    BISHOP MP; BUDDINGTON RW; ROBINSON WG; SILVA F
    J Neuropsychiatr; 1963 Oct; 4():28-32. PubMed ID: 14089790
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.